Tropic Biosciences
Develops high-performing commercial varieties of tropical crops using advanced genetic breeding (e.g. CRISPR) technologies.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD216—325m (Dealroom.co estimates Jul 2022.)
Company register number 10271134
Norwich England (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | <1m | <1m | <1m | 1.3m | <1m | 1.0m |
| % growth | - | - | 37 % | 96 % | 417 % | (39 %) | 26 % |
| EBITDA | (<1m) | (1.2m) | - | - | (12.1m) | (10.5m) | - |
| % EBITDA margin | - | (1284 %) | - | - | (922 %) | (1320 %) | - |
| Profit | (<1m) | (1.1m) | - | - | (9.8m) | (12.7m) | - |
| % profit margin | - | (1185 %) | - | - | (747 %) | (1589 %) | - |
| R&D budget | - | - | - | - | - | 2.1m | - |
| R&D % of revenue | - | - | - | - | - | 260 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | £140k | Grant | |
$10.0m | Series A | ||
£330k | Grant | ||
£160k | Grant | ||
$28.5m | Series B | ||
£690k | Grant | ||
£350k | Grant | ||
* | $35.0m | Late VC | |
| Total Funding | AUD117m | ||
Related Content
Recent News about Tropic Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.